An independent medical research institute rolls out a world’s first trial using AI-guided technology to detect heart failure and heart disease in remote areas of Australia.
The trial by the Baker Heart and Diabetes Institute investigates the effectiveness of AI- based echocardiography to triage and manage patients with known or suspected heart disease.
Late diagnoses of these heart conditions can lead to avoidable hospital admissions, poorer quality of life, and significant expense to the Australian health system and death. Aboriginal people and the elderly experience a disproportionate burden of these conditions.
The Wire’s Chloe White spoke with the Director of the Baker Institute and head of the clinical trial, Professor Tom Marwick, to find out more…
Produced By: Chloe White
Featured In Story: Professor Tom Marwick, Director of the Baker Institute and head of the clinical trial
First aired on The Wire, Monday 24 April 2023